Cargando…
Effects of cardiovascular medications on primary patency of hemodialysis arteriovenous fistula
While the patency of vascular access is essential for hemodialysis patients, optimal pharmaceutical treatment to maintain arteriovenous fistula (AVF) patency remains lacking. As cardiovascular diseases are highly prevalent in patients with end-stage renal disease, various cardiovascular medications...
Autores principales: | Chang, Te-I., Chen, Cheng-Hsien, Hsieh, Hui-Ling, Chen, Chun-You, Hsu, Shih-Chang, Cheng, Ho-Shun, Huang, Wen-Cheng, Sue, Yuh-Mou, Hsu, Yung-Ho, Lin, Feng-Yen, Shih, Chun-Ming, Lin, Shing-Jong, Huang, Po-Hsun, Liu, Chung-Te |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7376157/ https://www.ncbi.nlm.nih.gov/pubmed/32699337 http://dx.doi.org/10.1038/s41598-020-69019-6 |
Ejemplares similares
-
Luminal pressure gradient and risk of arteriovenous fistula nonmaturation
por: Kuo, Chi-Heng, et al.
Publicado: (2022) -
Study protocol for a prospective observational study to investigate the role of luminal pressure on arteriovenous fistula maturation
por: Cheng, Ho-Shun, et al.
Publicado: (2019) -
Inhibition of β-catenin signaling attenuates arteriovenous fistula thickening in mice by suppressing myofibroblasts
por: Liu, Chung-Te, et al.
Publicado: (2022) -
Statins Improve Long Term Patency of Arteriovenous Fistula for Hemodialysis
por: Chang, Hao-Hsiang, et al.
Publicado: (2016) -
The influence of atrial fibrillation on the mortality of incident ESRD patients undergoing maintenance hemodialysis
por: Hsieh, Hui-ling, et al.
Publicado: (2020)